Fapon drives innovation in the U.S. clinical market
19 Aug 2024
Learn about Fapon's key products tailored for the U.S. in vitro diagnostics market and its approach to meeting local needs. Narayan Krishnaswami, Regional Marketing Director, and Nick Guan, Vice President of Molecular Diagnostics R&D, discuss the company's clinical diagnostics strategy in the U.S. and highlight the contributions of Fapon's research centers in San Francisco and Boston.
Explore Fapon's future plans for expanding and strengthening its presence in the U.S., including innovations in Alzheimer's disease diagnostics and upcoming antibodies for vitamin D testing. Discover how Fapon is committed to catering to the unique demands of the U.S. market through continuous innovation and strategic localization. Plus, hear about Fapon's development plan for its highlighted product of the year, the Teloscript reverse transcriptase, and about the company's focus on infectious diseases such as influenza, COVID-19, syphilis, and HIV.
This video was filmed at ADLM 2024.
About the company
Fapon Group
Fapon is a global leading life sciences company dedicated to providing integrated solutions and services for diagnostics, biopharma and biotherapy. Integrating a one-stop solution on raw materials, reagents and innovative open instrument platforms, the Company has grown into a leading supplier in in-vitro diagnostics. Fapon boasts advanced innovations in therapeutics technologies and AI algorithm platforms with data insights that contribute to a better and healthier world. Supported by its strong global R&D, manufacturing, sales and service network, Fapon's products have established presence in 68 countries and regions, serving more than 2,500 business partners worldwide.
Related products
Request Quote for All Products
Shine i1000 Fully Automatic CLIA Analyzer
Fapon GroupThe smallest fully automated chemiluminescence analyzer, with large capacity, integrated computer and touch screen.